Related Experiment Videos

Lytic enzyme produced by Pseudomonas aeruginosa concomitantly with bacteriophage PS17. Purification,

Journal of Biochemistry
|January 1, 1981
PubMed

Insights

A novel bacteriolytic enzyme, PS17-lysozyme, was purified from Pseudomonas aeruginosa infected with phage PS17. This enzyme shows high specific activity and shares similarities with PR1-lysozyme, suggesting a potential relationship between pyocin R1 and phage PS17.

Area of Science:

  • Microbiology
  • Enzymology
  • Bacteriology

Background:

  • Pseudomonas aeruginosa infections can be treated with bacteriophages and their associated enzymes.
  • Bacteriolytic enzymes play a crucial role in phage replication and bacterial cell lysis.

Purpose of the Study:

  • To purify and characterize a bacteriolytic enzyme produced during Pseudomonas aeruginosa infection with phage PS17.
  • To compare the properties of this enzyme with other known lysozymes, particularly PR1-lysozyme.

Main Methods:

  • Purification of PS17-lysozyme using acrinol treatment and multiple chromatography steps (Amberlite CG-50, SP-Sephadex C-50).
  • Homogeneity assessment via three electrophoretic techniques.
  • Characterization of enzyme properties including pI, molecular weight, substrate specificity, and amino acid composition.

Main Results:

  • PS17-lysozyme was purified to homogeneity, revealing it to be a basic protein (pI 9-10) with a molecular weight of 24,500 Da.
  • The enzyme demonstrated substrate specificity similar to hen egg-white lysozyme but exhibited significantly higher specific activity against P. aeruginosa P14.
  • While similar to PR1-lysozyme, distinct chromatographic behavior and other properties indicated they are not identical.

Conclusions:

  • PS17-lysozyme is a distinct bacteriolytic enzyme produced by phage PS17-infected Pseudomonas aeruginosa.
  • The findings support the hypothesis that pyocin R1 might be a defective bacteriophage related to, but not identical with, phage PS17.

Related Concept Videos